Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CHOROIDEREMIA: Retinal Degeneration With an Unmet Need.
Pennesi ME, Birch DG, Duncan JL, Bennett J, Girach A. Pennesi ME, et al. Among authors: girach a. Retina. 2019 Nov;39(11):2059-2069. doi: 10.1097/IAE.0000000000002553. Retina. 2019. PMID: 31021898 Free PMC article. Review.
Measurement and Reproducibility of Preserved Ellipsoid Zone Area and Preserved Retinal Pigment Epithelium Area in Eyes With Choroideremia.
Hariri AH, Velaga SB, Girach A, Ip MS, Le PV, Lam BL, Fischer MD, Sankila EM, Pennesi ME, Holz FG, MacLaren RE, Birch DG, Hoyng CB, MacDonald IM, Black GC, Tsang SH, Bressler NM, Larsen M, Gorin MB, Webster AR, Sadda SR; Natural History of the Progression of Choroideremia (NIGHT) Study Group. Hariri AH, et al. Among authors: girach a. Am J Ophthalmol. 2017 Jul;179:110-117. doi: 10.1016/j.ajo.2017.05.002. Epub 2017 May 10. Am J Ophthalmol. 2017. PMID: 28499705
SCLERAL PITS IN CHOROIDEREMIA: Implications for Retinal Gene Therapy.
Al-Qahtani AA, Ba-Ali S, Alabduljalil T, Coyner AS, Patel RC, Weleber RG, Girach A, Christensen SK, Larsen M, Pennesi ME, Yang P. Al-Qahtani AA, et al. Among authors: girach a. Retina. 2018 Sep;38(9):1725-1730. doi: 10.1097/IAE.0000000000001957. Retina. 2018. PMID: 29160785 Free PMC article.
Macular spatial distribution of preserved autofluorescence in patients with choroideremia.
Hariri AH, Ip MS, Girach A, Lam BL, Fischer MD, Sankila EM, Pennesi ME, Holz FG, Maclaren RE, Birch DG, Hoyng CB, MacDonald IM, Black GC, Tsang SH, Bressler NM, Stepien KE, Larsen M, Gorin MB, Meunier I, Webster AR, Sadda S; For Natural History of the Progression of Choroideremia (NIGHT) Study Group. Hariri AH, et al. Among authors: girach a. Br J Ophthalmol. 2019 Jul;103(7):933-937. doi: 10.1136/bjophthalmol-2018-312620. Epub 2018 Oct 8. Br J Ophthalmol. 2019. PMID: 30297337 Free PMC article.
CHANGES IN RETINAL SENSITIVITY AFTER GENE THERAPY IN CHOROIDEREMIA.
Fischer MD, Ochakovski GA, Beier B, Seitz IP, Vaheb Y, Kortuem C, Reichel FFL, Kuehlewein L, Kahle NA, Peters T, Girach A, Zrenner E, Ueffing M, MacLaren RE, Bartz-Schmidt K, Wilhelm B. Fischer MD, et al. Among authors: girach a. Retina. 2020 Jan;40(1):160-168. doi: 10.1097/IAE.0000000000002360. Retina. 2020. PMID: 30308560 Clinical Trial.
Association between anatomical resolution and functional outcomes in the mivi-trust studies using ocriplasmin to treat symptomatic vitreomacular adhesion/vitreomacular traction, including when associated with macular hole.
Gandorfer A, Benz MS, Haller JA, Stalmans P, Pakola SJ, Girach A, Kampik A, Toth CA, Jaffe GJ; MIVI-TRUST Study Group. Gandorfer A, et al. Among authors: girach a. Retina. 2015 Jun;35(6):1151-7. doi: 10.1097/IAE.0000000000000508. Retina. 2015. PMID: 25741816 Clinical Trial.
Choroideremia Gene Therapy Phase 2 Clinical Trial: 24-Month Results.
Lam BL, Davis JL, Gregori NZ, MacLaren RE, Girach A, Verriotto JD, Rodriguez B, Rosa PR, Zhang X, Feuer WJ. Lam BL, et al. Among authors: girach a. Am J Ophthalmol. 2019 Jan;197:65-73. doi: 10.1016/j.ajo.2018.09.012. Epub 2018 Sep 19. Am J Ophthalmol. 2019. PMID: 30240725 Clinical Trial.
Oral protein kinase c β inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study 2.
Aiello LP, Vignati L, Sheetz MJ, Zhi X, Girach A, Davis MD, Wolka AM, Shahri N, Milton RC; PKC-DRS and PKC-DRS2 Study Groups. Aiello LP, et al. Among authors: girach a. Retina. 2011 Nov;31(10):2084-94. doi: 10.1097/IAE.0b013e3182111669. Retina. 2011. PMID: 21862954 Clinical Trial.
46 results